The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review
Crossref DOI link: https://doi.org/10.1038/srep04818
Published Online: 2014-04-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Long
Qiu, Xianxin
Wang, Rixiong
Xie, Xianhe
Text and Data Mining valid from 2014-04-28
Version of Record valid from 2014-04-28
Article History
Received: 19 March 2014
Accepted: 9 April 2014
First Online: 28 April 2014
Competing interests
: The authors declare no competing financial interests.